Similar Items: Durable response to sotorasib in KRAS G12C-mutant intrahepatic cholangiocarcinoma: a case report
- E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer
- Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma
- Acquired BRAF-AGK Fusion Following Osimertinib Plus Savolitinib in EGFR-Mutated MET-Amplified Non-Small-Cell Lung Cancer: Durable Response to Gefitinib and Trametinib in a Case Report
- Dynamic therapeutic response to osimertinib and immunotherapy in an EGFR L747S and L858R co-mutant NSCLC
- Mutant NPM1 in Acute Myeloid Leukemia Initiation and Maintenance
- Interleukin‐1α‐Mediated Activation of TNF‐α/NF‐κB Signaling Confers Resistance to Osimertinib in EGFR‐Mutant Non‐Small‐Cell Lung Cancer